{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:14:13Z","timestamp":1776406453640,"version":"3.51.2"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.crad.2021.04.013","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:43:29Z","timestamp":1622681009000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Imaging of the post-radiation chest in lung cancer"],"prefix":"10.1016","volume":"77","author":[{"given":"C.D.","family":"Strange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.-N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Vlahos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2021.04.013_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(01)01772-2","article-title":"Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma","volume":"52","author":"Bradley","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.clon.2010.06.013","article-title":"A review of the clinical evidence for intensity-modulated radiotherapy","volume":"22","author":"Staffurth","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.crad.2021.04.013_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijrobp.2011.06.1963","article-title":"Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience","volume":"83","author":"Jiang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2018.12.006","article-title":"Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer","volume":"131","author":"Verma","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2018.07.008","article-title":"Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer","volume":"129","author":"Haque","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cllc.2017.11.006","article-title":"Comparing the outcomes of stereotactic ablative radiotherapy and non-stereotactic ablative radiotherapy definitive radiotherapy approaches to thoracic malignancy: a systematic review and meta-analysis","volume":"19","author":"Hegi","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/1759-7714.12352","article-title":"Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: a meta-analysis","volume":"7","author":"Ma","year":"2016","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ijrobp.2014.05.055","article-title":"Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis","volume":"90","author":"Zheng","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13014-016-0693-8","article-title":"A critical review of recent developments in radiotherapy for non-small cell lung cancer","volume":"11","author":"Baker","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-0036-1592113","article-title":"Radiation therapy for stage I nonoperable or medically inoperable lung cancer","volume":"37","author":"Kishan","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.crad.2021.04.013_bib12","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11864-018-0588-z","article-title":"Proton therapy in non-small cell lung cancer","volume":"19","author":"Mesko","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2016.01.036","article-title":"Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer","volume":"95","author":"Chang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/1754-9485.12901","article-title":"Hypofractionated proton beam therapy for centrally located lung cancer","volume":"63","author":"Nakamura","year":"2019","journal-title":"J Med Imag Radiat Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/cancers7030831","article-title":"Proton beam therapy for non-small cell lung cancer: current clinical evidence and future directions","volume":"7","author":"Berman","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2021.04.013_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.seminoncol.2014.10.001","article-title":"Special cases for proton beam radiotherapy: re-irradiation, lymphoma, and breast cancer","volume":"41","author":"Plastaras","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21037\/tlcr.2018.03.22","article-title":"Proton therapy for thoracic reirradiation of non-small cell lung cancer","volume":"7","author":"Chao","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.crad.2021.04.013_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0360-3016(02)02928-0","article-title":"Dosimetric predictors of radiation-induced lung injury","volume":"54","author":"Marks","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/02841860802520821","article-title":"Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy","volume":"48","author":"Ricardi","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(02)02929-2","article-title":"Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy","volume":"54","author":"Yorke","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib22","first-page":"351","article-title":"Development of radiation pneumonitis: time and dose factor","volume":"74","author":"Jennings","year":"1962","journal-title":"Arch Pathol"},{"key":"10.1016\/j.crad.2021.04.013_bib23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2006.07.1337","article-title":"Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)","volume":"66","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0360-3016(02)03807-5","article-title":"Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer","volume":"55","author":"Tsujino","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jjco\/hyn158","article-title":"Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy\/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors","volume":"39","author":"Oh","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.7150\/jca.12314","article-title":"Analysis of clinical and dosimetric factors influencing radiation-induced lung injury in patients with lung cancer","volume":"6","author":"Han","year":"2015","journal-title":"J Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3109\/0284186X.2015.1061207","article-title":"Optimal fractionation in radiotherapy for non-small cell lung cancer\u2014a modelling approach","volume":"54","author":"Lindblom","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib28","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/JTO.0000000000000672","article-title":"Utilization of hyperfractionated radiation in small-cell lung cancer and its impact on survival","volume":"10","author":"Schreiber","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-8140(99)00087-0","article-title":"Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee","volume":"52","author":"Saunders","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2019.08.019","article-title":"One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial","volume":"105","author":"Singh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5306\/wjco.v10.i1.14","article-title":"Stereotactic body radiation therapy for non-small cell lung cancer: a review","volume":"10","author":"Prezzano","year":"2019","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib33","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.cllc.2017.06.021","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival in patients treated with lung stereotactic body radiation therapy (SBRT)","volume":"19","author":"Glick","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib34","first-page":"4909","article-title":"Impact of interstitial changes on radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"35","author":"Yoshitake","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.crad.2021.04.013_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thorsurg.2020.01.002","article-title":"Combining immunotherapy with radiation therapy in non-small cell lung cancer","volume":"30","author":"Fitzgerald","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.crad.2021.04.013_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2016.05.014","article-title":"Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer","volume":"98","author":"Boyer","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib37","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in Stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2021.04.013_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lungcan.2019.05.001","article-title":"Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer\u2014the ETOP NICOLAS trial","volume":"133","author":"Peters","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib39","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","article-title":"Maximizing tumor immunity with fractionated radiation","volume":"83","author":"Schaue","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib40","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.crad.2021.04.013_bib41","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.crad.2021.04.013_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1148\/rg.244035160","article-title":"Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis","volume":"24","author":"Choi","year":"2004","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2021.04.013_bib43","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib44","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1164\/ajrccm.158.6.9711036","article-title":"Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM\"O\"P)","volume":"158","author":"Crestani","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.crad.2021.04.013_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1183\/09031936.03.00071303","article-title":"Chronic eosinophilic pneumonia after radiation therapy for breast cancer","volume":"23","author":"Cottin","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.crad.2021.04.013_bib46","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.5301\/tj.5000274","article-title":"Bronchiolitis obliterans organizing pneumonia after radiation therapy for lung cancer: a case report","volume":"101","author":"Falcinelli","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.crad.2021.04.013_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canrad.2017.09.001","article-title":"Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: a case report","volume":"22","author":"Fanetti","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.crad.2021.04.013_bib48","first-page":"147","article-title":"Chronic eosinophilic pneumonia after radiation therapy for squamous cell lung cancer","volume":"22","author":"Nakayasu","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.crad.2021.04.013_bib49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2214\/ajr.178.6.1781383","article-title":"Radiation injury of the lung after three-dimensional conformal radiation therapy","volume":"178","author":"Koenig","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2021.04.013_bib50","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/JTO.0000000000000662","article-title":"Treatment and prognosis of isolated local relapse after stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: importance of salvage surgery","volume":"10","author":"Hamaji","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/JTO.0000000000000435","article-title":"Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist","volume":"10","author":"Huang","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0360-3016(90)90078-X","article-title":"The \"recall effect\" in radiotherapy: is subeffective, reparable damage involved?","volume":"18","author":"Kitani","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ajco.12447","article-title":"Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: case report and literature review","volume":"12","author":"Awad","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib55","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7","article-title":"Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel","volume":"76","author":"Schweitzer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0360-3016(02)02773-6","article-title":"Gemcitabine-induced radiation recall","volume":"53","author":"Jeter","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1748-717X-6-24","article-title":"Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer","volume":"6","author":"Ding","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib58","doi-asserted-by":"crossref","first-page":"FSO378","DOI":"10.2144\/fsoa-2018-0123","article-title":"Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review","volume":"5","author":"McGovern","year":"2019","journal-title":"Future Sci OA"},{"key":"10.1016\/j.crad.2021.04.013_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7888\/juoeh.42.261","article-title":"Pembrolizumab-induced radiation recall pneumonitis after the resolution of typical asymptomatic radiation pneumonitis","volume":"42","author":"Itamura","year":"2020","journal-title":"J UOEH"},{"key":"10.1016\/j.crad.2021.04.013_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12916-020-01718-3","article-title":"Radiation recall pneumonitis induced by PD-1\/PD-L1 blockades: mechanisms and therapeutic implications","volume":"18","author":"Teng","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.crad.2021.04.013_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2021.01.001","article-title":"Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer","volume":"157","author":"Cousin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib62","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ijrobp.2009.05.070","article-title":"Radiation dose-volume effects in the esophagus","volume":"76","author":"Werner-Wasik","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.radonc.2019.02.022","article-title":"A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy","volume":"137","author":"Zhao","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib64","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1748-717X-9-54","article-title":"Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy","volume":"9","author":"Zhang","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib66","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib67","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose-volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cllc.2019.05.014","article-title":"Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer","volume":"20","author":"Borkenhagen","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib69","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2214\/AJR.19.22741","article-title":"In situ pulmonary artery thrombosis: unrecognized complication of radiation therapy","volume":"215","author":"Ahuja","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2021.04.013_bib70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jrr\/rru107","article-title":"Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer","volume":"56","author":"Miura","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.crad.2021.04.013_bib71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2009.03.022","article-title":"Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis","volume":"91","author":"Pettersson","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2407-13-68","article-title":"Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors","volume":"13","author":"Nambu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.crad.2021.04.013_bib73","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.prro.2018.11.011","article-title":"Effect of tumor location and dosimetric predictors for chest wall toxicity in single-fraction stereotactic body radiation therapy for stage I non-small cell lung cancer","volume":"9","author":"Manyam","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib74","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2018.11.036","article-title":"Chest wall toxicity after stereotactic body radiation therapy: a pooled analysis of 57 studies","volume":"103","author":"Ma","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2021.04.013_bib75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2017.01.004","article-title":"Dose-effect analysis of radiation induced rib fractures after thoracic SBRT","volume":"123","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.crad.2021.04.013_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094859","article-title":"Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry","volume":"9","author":"Coroller","year":"2014","journal-title":"PLoS One"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021002531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021002531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:13:04Z","timestamp":1762114384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926021002531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0009926021002531"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2021.04.013","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of the post-radiation chest in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2021.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}